Form 4 for CELU Celularity Inc

Accepted 2022-04-28 00:00:00 ET · period of report 2022-04-13 · accession 0000899243-22-015912 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-04-28	2022-04-13	CELU	Hariri Robert J	CEO, Dir	A - Grant	—	+131.2K	7.87M	+2%	—
D	2022-04-28	2022-04-13	CELU	Hariri Robert J	CEO, Dir	A - Grant	$0.00	+384.8K	384.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-04-13	A	A	131,234	—	7,865,923	D	—	—	(F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
2	Derivative	Stock Option (Right to Buy)	2022-04-13	A	A	384,801	$0.00	384,801	D	$10.16 · — to 2032-04-13	384,801 Class A Common Stock	(F2) This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.